IL-33/ST2 axis promotes remodeling of the extracellular matrix and drives protective microglial responses in the mouse model of perioperative neurocognitive disorders

Int Immunopharmacol. 2023 Jan:114:109479. doi: 10.1016/j.intimp.2022.109479. Epub 2022 Nov 26.

Abstract

Anesthesia and surgery induce cognitive impairment via uncertain mechanisms. Increasing evidence has suggested that microglial activity mediated by IL-33 /ST2 plays a critical role in immune regulation and inflammatory responses. Yet, the implications for microglia activity mediated by IL-33 in perioperative neurocognitive disorders (PND) are not well established. We showed that IL-33 and ST2 were downregulated in the hippocampus after anesthesia and surgery, and the expression of aggrecan, remodeling by microglia, was upregulated. Meanwhile, the expression of pro-inflammatory cytokines (IL-6 and IL-1β) and M1-like microglia marker (iNOS) increased, and the expression of M2-like microglia marker (CD206) decreased. Notably, the administration of IL-33 attenuated neuroinflammation and shifted the polarization of microglia in the hippocampus after anesthesia and surgery. Furthermore, IL-33 treatment rescued the increase of aggrecan, loss of dendritic spines, and impairment of LTP, improving cognitive performance. In conclusion, our study suggests that microglia activity mediated by IL-33/ST2 plays a vital role in cognitive impairments after anesthesia and surgery, which may serve as a therapeutic target for PND.

Keywords: Extracellular matrix; IL-33; Microglia; Neuroinflammation; Perioperative neurocognitive disorders.

MeSH terms

  • Aggrecans / metabolism
  • Animals
  • Extracellular Matrix
  • Interleukin-1 Receptor-Like 1 Protein* / metabolism
  • Interleukin-33 / metabolism
  • Mice
  • Microglia* / metabolism
  • Neurocognitive Disorders / drug therapy
  • Neurocognitive Disorders / metabolism

Substances

  • Interleukin-1 Receptor-Like 1 Protein
  • Interleukin-33
  • Aggrecans